What Providers Need to Know About Pelvic Floor Therapy

Ideal candidates include adult men and women experiencing stress, urge, or mixed urinary incontinence. It’s particularly beneficial for patients with pelvic floor weakening related to aging, childbirth, menopause, or post-prostate surgery. The therapy offers a non-surgical option for those seeking improved bladder control and pelvic support. In addition to being FDA cleared for improving urinary incontinence, the ReStora EMS Chair is also cleared for strengthening pelvic floor muscles. For men, a weak pelvic floor is a known contributor to erectile dysfunction (ED).

This treatment is contraindicated for individuals who are pregnant or may be pregnant, as well as patients with implanted electronic devices (such as pacemakers or defibrillators), copper IUDs, or other metal implants near the pelvic region. A complete health history should be reviewed prior to treatment.

Most patients begin noticing results after one or two sessions. The recommended treatment protocol includes six sessions, scheduled as two 30-minute treatments per week for three weeks. Ongoing monthly maintenance sessions help sustain results over time.

No. Most patients tolerate ReStora EMS. Occasionally, patients may report temporary muscle soreness, mild spasms, or localized redness following treatment. These effects are short-lived and generally resolve on their own.

No. Patients typically describe the sensation as intense but manageable muscle contractions with a slight tingling feeling. There is no need for anesthesia or downtime, and most find the procedure comfortable and easy to complete.

While pricing is at the provider’s discretion, the recommended fee is $250 per session. Some providers offer package pricing for full treatment series or ongoing maintenance plans.

Patients should arrive in loose, comfortable clothing without metal elements near the pelvic area. Most remain fully clothed during the session, though minor adjustments may be needed in rare cases to ensure proper chair positioning.

Clinical use and patient feedback suggest a success rate of approximately 95%. Most patients report noticeable improvements in bladder control, pelvic muscle strength, and daily comfort following a full treatment course.

Yes. ReStora EMS is FDA-cleared for the treatment of urinary incontinence and pelvic floor muscle strengthening in adult men and women. It provides electromagnetic stimulation to re-educate and rehabilitate weakened pelvic floor muscles. *ReStora EMS was originally introduced under the name ReGenesis and was later rebranded as ReStora EMS. View FDA 510(k) K251026

There is no evidence to suggest that pelvic floor therapy using electromagnetic stimulation worsens incontinence. On the contrary, consistent treatment has been associated with significant improvements in muscle tone and symptom reduction.

You don’t have to make a large equipment purchase and simply hope the patient demand follows. ReStora is offered through a flexible rent to own model that allows you to introduce the service, build awareness, and evaluate how it performs within your own practice before making a long-term purchase decision. After the initial startup, the rental is $1,000 per month. Because each practice determines its own patient pricing, it does not necessarily take a high treatment volume for the service to begin contributing positively to the practice. Usually one or two patients a month will more than cover your rental payment. The goal is to give you an opportunity to build the service gradually rather than requiring a large patient base from day one.

No. Marketing support is part of the ReStora program. The startup package includes paid social media marketing to help generate awareness in your local market, along with installation and training. Trinity also provides patient-facing educational and promotional resources that practices can use to introduce the service to both existing and prospective patients. We don’t want to simply place a chair in your office. We want to help you successfully introduce the service and build patient awareness around it.

Patient pricing is determined by the practice, giving you the flexibility to set treatment pricing that makes sense for your patient population and local market. Many practices offer ReStora as a premium cash-pay service for patients actively looking for a comfortable, non-invasive option for pelvic floor strengthening and urinary incontinence. And you don’t have to predict patient demand perfectly before getting started. ReStora's rental model and initial evaluation period allow you to introduce the service and assess actual patient interest within your own practice rather than committing to a major equipment purchase upfront.

Not necessarily. In fact, for many practices, the cash-pay model is part of the opportunity. ReStora can add a revenue stream that is not dependent on insurance reimbursement, changing reimbursement rates, claim approvals, or lengthy payment cycles. The practice determines its own patient pricing and collects payment directly for the service. That can make ReStora a useful complement to a practice's insurance-based services while also giving patients access to an elective, non-invasive treatment option. Coverage and reimbursement can vary, so practices should always verify any specific billing or coding questions independently. Trinity generally positions ReStora as a cash-pay service rather than an insurance-dependent treatment model.

ReStora is generally offered as a cash-pay service, and our business model does not depend on insurance reimbursement or a particular CPT code. This gives practices more control over pricing and avoids building the financial viability of the service around whether an insurer approves or reimburses a particular treatment. Because coding and coverage can vary by payer, provider, and clinical circumstance, any practice considering insurance billing should independently verify the appropriate coding and reimbursement requirements.

Our standard startup program has an established upfront cost because it includes the components needed to properly launch ReStora in the practice. However, we understand that every practice's financial situation is different. In certain circumstances, Trinity may be able to discuss alternative payment arrangements. These arrangements are evaluated individually and aren't guaranteed, but if the startup cost is the main thing holding you back, it's worth discussing with our team rather than assuming ReStora isn't an option.

ReStora has a relatively compact footprint. The chair itself is approximately 26 inches high by 25 inches wide, so it doesn't require a large dedicated treatment room. In most cases, a space of approximately 4 × 4 feet provides plenty of room for the chair and comfortable patient access. This makes it practical for many offices that don't have a large amount of unused treatment space.

ReStora EMS is an FDA-cleared Class II medical device for strengthening the pelvic floor muscles. Pelvic floor weakness can contribute to urinary leakage in both men and women and may also play a role in sexual wellness in both men and women. By stimulating deep pelvic floor muscle contractions, ReStora is designed to help strengthen this important muscle group. It uses electromagnetic stimulation to create deep pelvic floor muscle contractions while the patient remains comfortably seated and fully clothed. We also believe providers should have the opportunity to evaluate more than a sales presentation. That's one reason ReStora includes an initial evaluation period, allowing practices to experience the technology and assess how it fits their own patient population and practice.

A lower price doesn't mean ReStora is cutting corners on regulatory status or the fundamental technology. ReStora is an FDA-cleared Class II medical device. A significant part of the difference comes from how our business is structured. Trinity operates a smaller, efficient organization with relatively low operational overhead. We also avoid many of the expensive financing structures and layers of cost that can ultimately get built into the price of medical equipment. ReStora itself is also designed as a more compact system. Our approach is straightforward: keep our operations efficient, keep the acquisition model simple, and make pelvic floor technology financially accessible to more practices rather than adding unnecessary costs that ultimately have to be passed on to the customer.

The calculator displays the current assumptions being used in the projection, including the ReStora monthly rental, startup cost, and follow-up treatment assumption. For complete and current acquisition terms, fees, and program details, please review our Pricing page or speak with the Trinity Medical Solutions team.

No. The calculator is a planning tool, not a guarantee of revenue or profitability. Actual results will depend on factors such as patient demand, treatment pricing, operating expenses, patient retention, and how your practice implements and markets the service. The projection is intended to help you evaluate realistic scenarios and start an informed conversation about whether ReStora EMS is a good fit for your practice.